Vaccines have emerged as one of the most profitable
business segments in the healthcare industry. The
market is expected to grow from $20 Billion in 2008 to
over $30 Billion in 2013. Historical growth has been
fueled by demand in the developed nations. However,
future growth will be fueled by a huge unmet need in the
emerging markets (India, China, Latin America, Africa).
Large pharmaceutical companies, namely, Sanofi
Pasteur, GlaxoSmithKline, Merck, Novartis and Pfizer
(formerly Wyeth) account for almost 80% of sales.
The growth has been driven by the emergence of new
vaccines and an increasing demand for seasonal
flu vaccines. Future growth is expected to be driven by
the launch of new vaccines, increasing trends of
routine immunization and increasing support from the
governments of various countries. It is expected
that growth in demand for adult vaccines will outpace the
growth in demand for pediatric vaccines.